Author:
Rabe Thomas,Runnebaum Benno
Publisher
Springer Berlin Heidelberg
Reference76 articles.
1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 369: 64–67
2. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbrouke JP (1995) Enhancement by factor V Leiden mutation of risk of deep vein thrombosis associated with oral contraceptives containing a third generation progestagen. Lancet 346: 1593–96
3. Bonnar J, Daly L, Sabra A, Carroll A (1988) Effects of oral contraception on blood clotting. In: Runnebaum B, Rabe T, Kiesel L (eds) Female contraception, update and trends. Springer-Verlag, Berlin Heidelberg New York, pp 56–59
4. Bottinger LE, Boman G, Eklund G, Westerholm B (1980) Oral contraceptives and thromboembolic disease. Effects of lowering oestrogen content. Lancet i: 1097
5. Bowes WA, Katta LR, Droegemueller W, Braight TG (1989) Triphasic randomized clinical trial. Comparison of effects on carbohydrate metabolism. Am J Obstet Gynecol 161: 1402